Thursday 18 February 2021
Investor Ideas #Potcasts 532, #Cannabis News and #Stocks on the Move; Interview with Paul Rosen, CEO of 1933 Industries (CSE: $TGIF.C) (OTC: $TGIFF)
Investor Ideas #Potcasts
532, #Cannabis News and #Stocks on the Move; Interview with Paul Rosen, CEO of
1933 Industries (CSE: $TGIF.C) (OTC: $TGIFF)
Delta, Kelowna, BC, February 18, 2021 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/02181TGIF-Interview.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast Investorideas interviews Paul
Rosen, CEO of 1933 Industries (CSE:
TGIF) (OTC: TGIFF), where
we discussed the current trends surrounding the cannabis industry, current
investor sentiment, what are the current expectations surrounding regulatory
reform in the US and how 1933 Industries\ home market of Nevada is expected to
grow and evolve moving forward.
Paul
Rosen is a noted career entrepreneur, management consultant
and public speaker. Over the last 8 years Paul has become one of the most
active entrepreneurs, advisors and investors in the emerging global cannabis
industry. Paul Rosen was a co-founder of PharmaCan
Capital Corp. (Now Cronos Group Inc.) (NASDAQ:
CRON) (TSX:
CRON) and served as its first President and CEO. Paul has
held board positions with a number of publicly-traded cannabis companies and
currently serves as the Executive Chairman of Global Go, a consultancy focused
on the global regulated cannabis industry.
Paul has enjoyed a distinguished
speaking and media career. He has appeared on/in Bloomberg, CNN, CNBC, Fox
Business, BBC Business, Nasdaq TV, Yahoo Finance, The Economist, The Street,
Barrons, National Public Radio and Cheddar TV. Paul is a member of the Law
Society of Upper Canada and received a B.A. in Economics from Western University
in 1985 and an LL.B. from the University of Toronto in 1988.
Since January, cannabis stocks have
seen a flourish of positive
trading and investor sentiment, in part due to a
trend of positive financial results as well as high expectations surrounding
the Democratic majority hopefully pushing more cannabis regulatory reform.
When asked about the current
optimism surrounding the cannabis industry today Mr. Rosen commented, “my
optimism was never misplaced. Cannabis is a young industry that has already
gone through operatic cycles of peaks and pull backs which is typically
expected of an early stage industry, but what we should say is the
“thesis”around Cannabis has only gone in one direction and that’s straight up.
We have to separate the day to day fickleness of investor sentiment with what’s
actually happening with the economy of cannabis, and what’s happening the
economy of cannabis is month after month sales growth, almost without
interruption. I think you can look back on those barrish periods and look at
them as buying opportunities, I know I did. I never doubted at a macro level
that the industry was under any distress, individual companies were under
distress, but the industry has been performing even above most optimistic
projections.”
Mr Rosen continued, “There is now an
almost irrevocable momentum towards cannabis reform at a global level. We’re
going to look back at today’s cannabis economy a decade from now and realize
how small it still was. The so-called once in a lifetime opportunity is a
chance to help build an industry that inevitably is going to attract the
attention and potential market weight of big pharma and big CPG, but to be able
to build defendable assets before that happens writ large.”
When asked some of the advantages
surrounding the US cannabis industry, and specifically Nevada, Mr. Rosen
commented, “I like Nevada a lot from the macroeconomic perspective. Nevada has
been a market where the cannabis control board has been more discretionary in
the granting of licenses and less administrative. So on the supply demand
economics it was a limited supply state and when you introduce the velocity of
tourism, in a regular pre-COVID economy, it had a remarkable demand. One thing
we’ve learned during COVID was that Nevada was not as dependent on the tourism
market as we had though, there is a very healthy domestic market there, but
once tourism comes back it comes back to supply and demand. Let’s say tourism
returns to normal 6 months from now, which is going to more than double the
total addressable market, there won’t be a two-times response in available
capacity.”
|Mr. Rosen went on to comment on the
speculation surrounding legalization in the US saying, “I predict, and I am far
from alone in this, this a consensus point of thought leaders in our industry,
that we will see a series of incremental congressional initiatives succeed in
this congress in the next 24 months before midterms. We all know these acronyms
like they’re the names of our pets; the SAFE
Act,
MORE
Act
and STATES
Act.
Exactly which os those congressional initiatives passed first? I hope it’s the
SAFE Act, because the banking act would be the most transformative as one
single piece of legislation for the development of the industry. Any one of
them would have the same effect, it’s just the effect would be more pronounced
with SAFE. As to legalization, well it’s coming, but the question is what it’s going
to look like? The question to drill down to is where is cannabis going to show
up on the Schedule on the controlled substances act? If I could have my
druthers I would say deschedule cannabis, take it right out the controlled
substances act, pass those legislations and reap the benefits of a dynamic
industry that favours nearly every constituency and causes little to no social
harm.”
Mr. Rosen went on to discuss the expected
clarification from the FDA surrounding the CBD industry in the
US, how the WallStreetBets
community has recently focussed on the cannabis sector,
synthesis versus full and partial spectrum products, the emergence of
psychedelics and what investors and consumers should look forward to in the
cannabis industry in 2021 and beyond.
Investor ideas reminds all listeners
to read our disclaimers and disclosures on the Investorideas.com website and
that this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading
apps including Robinhood , Acorn, Stash and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Wednesday 17 February 2021
Tuesday 16 February 2021
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...